Gsk-3β Inhibitors Mimic the Cardioprotection Mediated by Ischemic Pre- and Postconditioning in Hypertensive Rats

Table 1

Body weight (BW), heart weight (HW), heart weight/body weight ratio ((HW/BW)∗1000), left ventricular end diastolic pressure (LVEDP), left ventricular developed pressure (LVDP), and maximal velocity of rise of left ventricular pressure (+dP/dt_max) in all experimental groups.

Group	BW (g)	HW (g)	HW/BW	LVEDP (mmHg)	LVDP (mmHg)	+𝑑𝑃/𝑑𝑡max  (mmHg/sec)
NIC	336±12	1.50±0.04	4.5±0.1	10±1	91±1	2332±14
IC	328±6	1.53±0.07	4.7±0.2	13±2	88±6	2340±126
PRE	329±13	1.43±0.04	4.4±0.2	12±1	87±7	2318±147
POS	325±13	1.52±0.07	4.7±0.2	10±1	89±6	2393±129
LiClpre	328±5	1.46±0.05	4.5±0.2	12±1	87±4	2300±98
LiClpos	325±10	1.46±0.03	4.5±0.2	10±1	91±2	2333±39
PRE + W	340±12	1.60±0.07	4.7±0.2	10±2	86±8	2260±120
POS + W	332±6	1.52±0.05	4.6±0.2	11±1	86±8	2280±150
IMIpre	330±3	1.54±0.03	4.7±0.1	12±1	90±1	2338±100
IMIpos	322±10	1.52±0.05	4.7±0.2	11±1	89±4	2310±130